Global Artificial Heart Market 2019-2023

人工心臓の世界市場2019-2023

◆タイトル:Global Artificial Heart Market 2019-2023
◆商品コード:IRTNTR31298
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年5月16日
◆ページ数:117
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:Health Care
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、人工心臓の世界市場について調査・分析し、市場概要、市場環境、人工心臓市場規模、製品別(VAD、TAH)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・人工心臓の世界市場概要
・人工心臓の世界市場環境
・人工心臓の世界市場動向
・人工心臓の世界市場規模
・人工心臓の世界市場:業界構造分析
・人工心臓の世界市場:製品別(VAD、TAH)
・人工心臓の世界市場:地域別市場規模・分析
・人工心臓の北米市場規模・予測
・人工心臓のヨーロッパ・中東・アフリカ市場規模・予測
・人工心臓のアジア太平洋市場規模・予測
・人工心臓の主要国分析
・人工心臓の世界市場:意思決定フレームワーク
・人工心臓の世界市場:成長要因、課題
・人工心臓の世界市場:競争環境
・人工心臓の世界市場:関連企業情報(ベンダー分析)

About this market
Advances in VAD technology will be a key factor driving the growth of the market. The newer generation VADs use several new technologies such as direct flow measurement and remote parameter monitoring and are capable of a wide range of flow for full and/or partial support. They have significantly enhanced survival rates, better quality of life, and device durability with reduced device-related complication rates. Such technological advances and product launches are expected to increase the demand for VADs, which in turn, drives the market. Technavio’ s analysts have predicted that the artificial heart m market will register a CAGR of almost 9% by 2023.
Market Overview
Increasing prevalence of HF and associated risk factors
The prevalence of HF has been steadily increasing in developing as well as developed countries. In Europe, HF affects 20,000 out of one million people in the general population. The prevalence of HF in western countries is estimated to be around 10,000 to 20,000 out of one million individuals, and the average incidence is around 7,500 per million persons each year. Furthermore, the number of hospital admissions due to HF has also been steadily increasing in several countries. This, in turn, will increase the demand for artificial hearts.
High cost of artificial hearts
The high cost of VADs and TAHs is restricting their widespread adoption in developed as well as developing countries. Vendors offering artificial hearts can charge high prices in part due to structural barriers to competition such as the complex and costly regulatory approval process, and patent protection. These barriers hinder the import of artificial hearts that might compete with domestically manufactured devices and reduce the prices. Hence, the high cost of artificial hearts and procedures are hampering the growth of the global artificial heart market.
For the detailed list of factors that will drive and challenge the growth of the artificial heart market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be highly concentrated. The presence of few companies including ReliantHeart Inc. and SynCardia Systems LLC makes competitive environment is quite intense. Factors such as the advances in VAD and increasing prevalence of HF and associated risk factors, will provide considerable growth opportunities to artificial heart manufactures. Abbott, Abiomed Inc., Medtronic, ReliantHeart Inc., and SynCardia Systems LLC are some of the major companies covered in this report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• VAD – Market size and forecast 2018-2023
• TAH – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Clinical trials for the development of TAHs
• Focus on development of non-blood-contacting VADs
• Strategic acquisitions
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• Abiomed Inc.
• Medtronic
• ReliantHeart Inc.
• SynCardia Systems LLC
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Product – Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: VAD – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: VAD – Year-over-year growth 2019-2023 (%)
Exhibit 21: TAH – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: TAH – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America – Year-over-year growth 2019-2023 (%)
Exhibit 29: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 31: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 33: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Abbott – Vendor overview
Exhibit 44: Abbott – Business segments
Exhibit 45: Abbott – Organizational developments
Exhibit 46: Abbott – Geographic focus
Exhibit 47: Abbott – Segment focus
Exhibit 48: Abbott – Key offerings
Exhibit 49: Abbott – Key customers
Exhibit 50: Abiomed Inc. – Vendor overview
Exhibit 51: Abiomed Inc. – Product segments
Exhibit 52: Abiomed Inc. – Organizational developments
Exhibit 53: Abiomed Inc. – Segment focus
Exhibit 54: Abiomed Inc. – Key offerings
Exhibit 55: Abiomed Inc. – Key customers
Exhibit 56: Medtronic – Vendor overview
Exhibit 57: Medtronic – Business segments
Exhibit 58: Medtronic – Organizational developments
Exhibit 59: Medtronic – Geographic focus
Exhibit 60: Medtronic – Segment focus
Exhibit 61: Medtronic – Key offerings
Exhibit 62: Medtronic – Key customers
Exhibit 63: ReliantHeart Inc. – Vendor overview
Exhibit 64: ReliantHeart Inc. – Product segments
Exhibit 65: ReliantHeart Inc. – Organizational developments
Exhibit 66: ReliantHeart Inc. – Key offerings
Exhibit 67: ReliantHeart Inc. – Key customers
Exhibit 68: SynCardia Systems LLC – Vendor overview
Exhibit 69: SynCardia Systems LLC – Product segments
Exhibit 70: SynCardia Systems LLC – Organizational developments
Exhibit 71: SynCardia Systems LLC – Key offerings
Exhibit 72: SynCardia Systems LLC – Key customers
Exhibit 73: Validation techniques employed for market sizing
Exhibit 74: Definition of market positioning of vendors



【掲載企業】

Abbott、Abiomed Inc.、Medtronic、ReliantHeart Inc.、SynCardia Systems LLC

★調査レポート[人工心臓の世界市場2019-2023] (Global Artificial Heart Market 2019-2023 / IRTNTR31298)販売に関する免責事項
[人工心臓の世界市場2019-2023] (Global Artificial Heart Market 2019-2023 / IRTNTR31298)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆